Auryxia and Idhifa

• Generic Name: ferric citrate
• Dosage Forms: tablet, coated
• Other Brand Names: Auryxia

Auryxia contains iron that binds to the phosphates you take in through food, which helps your body absorb fewer phosphates. This can lower the amount of phosphorus (a mineral) in your blood.

Auryxia is used to control phosphorus levels in adults with chronic kidney disease who are on dialysis.

Auryxia is also used to treat iron deficiency anemia in adults with chronic kidney disease who are not on dialysis.

Auryxia may also be used for purposes not listed in this medication guide.

• Generic Name: enasidenib
• Dosage Forms: tablet, film coated
• Other Brand Names: Idhifa, Idhifa

IDHIFA (enasidenib) targets a specific gene mutation called IDH2, which can affect your bone marrow. IDH2 mutation prevents young blood cells from developing into healthy adult blood cells, which can result in symptoms of acute myeloid leukemia.

IDHIFA is used to treat acute myeloid leukemia in adults with an IDH2 mutation.

IDHIFA is used when AML has come back or has not improved with prior treatment.